Side Liu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Colorectal Cancer Screening and Detection
- Cancer Cells and Metastasis
Papers in
- Oncology 50
- Colorectal Cancer Screening and Detection 25
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 5
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Aimin Li (44 shared papers)Qiuhua Lai (19 shared papers)Fachao Zhi (18 shared papers)Yuxin Fang (16 shared papers)Qun Yan (12 shared papers)Qingyuan Li (17 shared papers)Chun-Cai Gu (10 shared papers)Xinke Wang (11 shared papers)
- Journals
- Cell Death and Disease (7 papers)PLoS ONE (6 papers)Endoscopy (6 papers)Frontiers in Oncology (4 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Side Liu
137 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 680
- Oncology 1.1k
- Molecular Biology 1.4k
- Internal Medicine 58
- Drug Discovery 5
Countries citing papers authored by Side Liu
This map shows the geographic impact of Side Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Side Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Side Liu more than expected).
Fields of papers citing papers by Side Liu
This network shows the impact of papers produced by Side Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Side Liu. The network helps show where Side Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Side Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 269 | |
| 2 | 2015 | 222 | |
| 3 | 2019 | 177 | |
| 4 | 2020 | 171 | |
| 5 | 2020 | 146 | |
| 6 | 2018 | 145 | |
| 7 | 2018 | 142 | |
| 8 | 2020 | 105 | |
| 9 | 2015 | 100 | |
| 10 | 2019 | 91 | |
| 11 | 2020 | 90 | |
| 12 | 2019 | 89 | |
| 13 | 2020 | 85 | |
| 14 | 2017 | 80 | |
| 15 | 2020 | 75 | |
| 16 | 2018 | 74 | |
| 17 | 2016 | 71 | |
| 18 | 2018 | 63 | |
| 19 | 2020 | 60 | |
| 20 | 2012 | 59 |
About Side Liu
Side Liu is a scholar working on Oncology, Cancer Research, Molecular Biology, Gastroenterology and Surgery, having authored 145 papers that have together received 4.3k indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (25 papers), Inflammatory Bowel Disease (10 papers), Gastrointestinal Bleeding Diagnosis and Treatment (8 papers), Mechanisms of cancer metastasis (8 papers), Cancer Cells and Metastasis (8 papers), Gastric Cancer Management and Outcomes (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (680 citations), Oncology (1.1k citations), Molecular Biology (1.4k citations), Internal Medicine (58 citations) and Drug Discovery (5 citations). Side Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Aimin Li, Qiuhua Lai, Fachao Zhi, Yuxin Fang, Qun Yan, Qingyuan Li, Chun-Cai Gu, Xinke Wang, Yue Zhang and Xiaobei Luo. Their work appears in journals such as Cell Death and Disease, PLoS ONE, Endoscopy, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.